Current human surveillance does not show increased MTC incidence with GLP-1 use, but informed decision-making and closer thyroid ultrasound screening may be warranted in high-risk individuals
Scientific & Chemical Identification CAS Number: 121062-08-6 Molecular Formula: CHNO Molecular Weight (M.W.): ~1024.18 g/mol Amino Acid Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH Synonyms: Melanotan II, MT-II Peptide Mechanism & Receptor Activity Melanotan-II acts as a non-selective agonist at melanocortin receptors (MC1R, MC3R, MC4R, and MC5R) , mimicking certain effects of endogenous -MSH in research models
Withaferin A, as a steroid isolated from Withania somnifera , is a natural ferritin inducer for neuroblastoma, dose-dependently either activates the NRF2 pathway through targeting of Kelch-like ECH-associated protein 1 (KEAP1) or aspartate aminotransferase (GPX4) to induce ferroptosis [171, 172]
Several observations suggest a possible action of GLP-1 on thirst-regulatory mechanisms, since GLP-1R mRNA has been located in brain areas related to the control of thirst, such as the preoptic area, glial cells lining the third ventricle and, especially, the neurons of the PVN, which is a key station for water balance regulation through the antidiuretic effects of vasopressin released by its projection to the neurohypophysis [44]
Glucagon-like peptide-1 gastrointestinal regulatory role in metabolism and motility
Alterations in the secretion and/or sensitivity to GH and IGF-1 may serve as risk factors for the development of several brain diseases or as their correlates